Latest News & Features
Americas
The Life Sciences Law Forum opened today, June 25, with a lively panel on the implications of online technology for innovative companies in the sector, including the knock on effect for intellectual property rights. 25 June 2015
Americas
The judiciary system for the new Unified Patent Court has been the subject of much discussion. As part of a regular column, Paul England, senior associate at law firm Taylor Wessing and who chaired a recent discussion between a panel of experts, examines the issue. 25 June 2015
Americas
A group of individuals has reportedly launched a class action lawsuit against Novartis to stop it enforcing a so-called ‘pay-for-delay’ settlement agreement with generic drug maker Sun Pharma centring on leukaemia drug Gleevec. 25 June 2015
Americas
US law firm Nutter McClennen & Fish has boosted its intellectual property team in Boston with the appointment of Patrick Concannon as partner. 24 June 2015
Americas
The US Food and Drug Administration, along with international police organization Interpol, has targeted more than 1,000 websites that sell fake, unapproved medicines and medical devices. 24 June 2015
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court ruling which said that a reissue patent covering Pfizer’s arthritis drug Celebrex was invalid for obviousness-type double patenting. 24 June 2015
Asia-Pacific
China’s State Intellectual Property Office has rejected Gilead Sciences’s patent application covering its Sovaldi (sofosbuvir) drug after it was challenged by a non-profit group. 23 June 2015
Americas
A US appeals court has for the second time invalidated a patent covering pharmaceutical company Teva’s multiple sclerosis drug Copaxone. 22 June 2015
Big Pharma
Law firm Pinsent Masons has expanded its Munich office with the hire of Marc Holtorf as partner. 22 June 2015
Americas
US law firm Honigman Miller Schwartz and Cohn has hired two intellectual property lawyers as partners. 19 June 2015